Revision history of "US Food and Drug Administration FDA placed a Boxed Warning for enhanced risk of mortality from gout prescription drug Uloric febuxostat"

Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 12:48, 19 September 2019‎ Boesen91thorpe (talk | contribs)‎ . . (1,336 bytes) (+1,336)‎ . . (Created page with "conduct a large postmarket safety clinical trial. The trial was conducted in over 6,000 patients with gout treated with either Uloric or allopurinol. The primary result was a...")
Retrieved from "https://elearnportal.science/wiki/US_Food_and_Drug_Administration_FDA_placed_a_Boxed_Warning_for_enhanced_risk_of_mortality_from_gout_prescription_drug_Uloric_febuxostat"